Nancy Braverman

10.0k total citations · 2 hit papers
113 papers, 6.0k citations indexed

About

Nancy Braverman is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Nancy Braverman has authored 113 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 29 papers in Clinical Biochemistry and 20 papers in Physiology. Recurrent topics in Nancy Braverman's work include Peroxisome Proliferator-Activated Receptors (65 papers), Metabolism and Genetic Disorders (29 papers) and Adipose Tissue and Metabolism (13 papers). Nancy Braverman is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (65 papers), Metabolism and Genetic Disorders (29 papers) and Adipose Tissue and Metabolism (13 papers). Nancy Braverman collaborates with scholars based in Canada, United States and Germany. Nancy Braverman's co-authors include Ann B. Moser, Hugo W. Moser, Gabriele Dodt, David Valle, Steven J. Steinberg, Gerald V. Raymond, Cassandra Obie, Gary Steel, Erminia Di Pietro and Daniela D’Agostino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Nancy Braverman

109 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Functions of plasmalogen lipids in health and disease

2012 781 citations Nancy Braverman, Ann B. Moser Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease profile →
Phenylalanine hydroxylase deficiency: diagnosis and management guideline

2014 465 citations Nancy Braverman et al. Genetics in Medicine profile →

Peers

Countries citing papers authored by Nancy Braverman

Since Specialization

Citations

This map shows the geographic impact of Nancy Braverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Braverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Braverman more than expected).

Fields of papers citing papers by Nancy Braverman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Braverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Braverman. The network helps show where Nancy Braverman may publish in the future.

Co-authorship network of co-authors of Nancy Braverman

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Braverman. A scholar is included among the top collaborators of Nancy Braverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Braverman. Nancy Braverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using multiple modalities to confirm diagnosis in patients with suspected peroxisome biogenesis disorders 2025 ·Molecular Genetics and Metabolism ·Anthony Cheung, Erminia Di Pietro, (unknown), Eric Bareke, (unknown), Ratna Dua Puri, (unknown), Rebecca Ganetzky, Amy B. Goldstein, Adeline Vanderver, Shruthi Mohan, Jacek Majewski, (unknown), Nancy Braverman	0
2	Estimation of PEX1-mediated Zellweger spectrum disorder births and population prevalence by population genetics modeling 2025 ·Genetics in Medicine Open ·Karen E. Malone, (unknown), (unknown), Nancy Braverman	0
3	Evaluating the strength of evidence for genes implicated in peroxisomal disorders using the ClinGen clinical validity framework and providing updates to the peroxisomal disease nomenclature 2023 ·Molecular Genetics and Metabolism ·Shruthi Mohan, (unknown), Meredith Weaver, (unknown), Irene De Biase, Jennifer Goldstein, Rong Mao, Jennifer McGlaughon, Ann B. Moser, Aurora Pujol, Sharon F. Suchy, Tatiana Yuzyuk, Nancy Braverman	0
4	Overlapping and Distinct Features of Cardiac Pathology in Inherited Human and Murine Ether Lipid Deficiency 2023 ·International Journal of Molecular Sciences ·Fabian Dorninger, Attila Kiss, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Theresa König, Michael B. Bober, Tíscar Cavallé-Garrido, Nancy Braverman, Sonja Forss‐Petter, Christian Pifl, Jan Bauer, Reginald E. Bittner, Thomas H. Helbich, Bruno K. Podesser, Hannes Todt, Johannes Berger	1
5	A new test method for biochemical analysis of plasmalogens in dried blood spots and erythrocytes from patients with peroxisomal disorders 2023 ·Journal of Inherited Metabolic Disease ·(unknown), Amy White, (unknown), (unknown), Devin Oglesbee, Dietrich Matern, Silvia Tortorelli, Kimiyo Raymond, Nancy Braverman, Dimitar K. Gavrilov	1
6	Quantitative analysis of ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry for diagnosing peroxisome biogenesis disorders 2023 ·Clinica Chimica Acta ·Irene De Biase, Tatiana Yuzyuk, Wei Cui, (unknown), Ann B. Moser, Nancy Braverman	2
7	Clinical diagnosis of metabolic disorders using untargeted metabolomic profiling and disease-specific networks learned from profiling data 2022 ·Scientific Reports ·(unknown), Xiqi Li, Lindsay C. Burrage, Kevin Riehle, Joseph G. Hacia, Nancy Braverman, Michael F. Wangler, Marcus J. Miller, Sarah H. Elsea, Aleksandar Milosavljevic	18
8	The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder 2021 ·EMBO Reports ·Esther Nuebel, Jeffrey T. Morgan, Sarah Fogarty, Jacob M. Winter, Sandra Lettlová, Jordan A. Berg, Yu‐Chen Chan, (unknown), J. Alan Maschek, Katie J. Clowers, (unknown), (unknown), Ilka Wittig, James E. Cox, Minna Roh‐Johnson, Nancy Braverman, Joshua L. Bonkowsky, Steven P. Gygi, Jared Rutter	29
9	AAV-mediated PEX1 gene augmentation improves visual function in the PEX1-Gly844Asp mouse model for mild Zellweger spectrum disorder 2021 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Anna Polosa, (unknown), Samy Omri, (unknown), Bruno Cécyre, Devin S. McDougald, Erminia Di Pietro, Jean‐François Bouchard, Jean Bennett, Joseph G. Hacia, Pierre Lachapelle, Nancy Braverman	13
10	Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG) 2019 ·Genetics in Medicine ·Irene De Biase, Silvia Tortorelli, Lisa E. Kratz, Steven J. Steinberg, Kristina Cusmano‐Ozog, Nancy Braverman	14
11	VAPs and ACBD5 tether peroxisomes to the ER for peroxisome maintenance and lipid homeostasis 2017 ·The Journal of Cell Biology ·Rong Hua, D. Cheng, Étienne Coyaud, Spencer A. Freeman, Erminia Di Pietro, Yuqing Wang, Adriano Vissa, Christopher M. Yip, Gregory D. Fairn, Nancy Braverman, John H. Brumell, William S. Trimble, Brian Raught, Peter K. Kim	214
12	Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis 2017 ·Cell Death and Differentiation ·Michael S. Dahabieh, (unknown), Erminia Di Pietro, (unknown), Alicia M. Bolt, Christophe Gonçalves, Daphné Dupéré-Richer, Filippa Pettersson, Koren K. Mann, Nancy Braverman, Sonia V. del Rincón, Wilson H. Miller	35
13	Allelic Expression Imbalance Promoting a Mutant PEX6 Allele Causes Zellweger Spectrum Disorder 2017 ·The American Journal of Human Genetics ·Kim D. Falkenberg, Nancy Braverman, Ann B. Moser, Steven J. Steinberg, Femke C. C. Klouwer, Agatha Schlüter, Montserrat Ruíz, Aurora Pujol, Martin Engvall, K Naess, (unknown), (unknown), M. Estela Rubio‐Gozalbo, Sacha Ferdinandusse, Ronald J. A. Wanders, Hans R. Waterham	34
14	Low bone mineral density is a common feature of Zellweger spectrum disorders 2015 ·Molecular Genetics and Metabolism ·Eric T. Rush, (unknown), Nancy Braverman, William B. Rizzo	13
15	Functions of plasmalogen lipids in health and disease breakdown → 2012 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Nancy Braverman, Ann B. Moser	781
16	A founder mutation in the PEX6 gene is responsible for increased incidence of Zellweger syndrome in a French Canadian population 2012 ·BMC Medical Genetics ·Sébastien Lévesque, Charles Morin, Simon‐Pierre Guay, (unknown), Pascale Marquis, (unknown), Sarn Jiralerspong, Luigi Bouchard, Steven J. Steinberg, Joseph G. Hacia, Ken Dewar, Nancy Braverman	31
17	A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton 2009 ·Molecular Genetics and Metabolism ·Nancy Braverman, Rui Zhang, Li Chen, Graeme Nimmo, (unknown), Tammy Tran, (unknown), Ann B. Moser, Steven J. Steinberg	51
18	Peroxisome biogenesis disorders 2006 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Steven J. Steinberg, Gabriele Dodt, Gerald V. Raymond, Nancy Braverman, Ann B. Moser, Hugo W. Moser	379
19	The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum 2004 ·Molecular Genetics and Metabolism ·Steven J. Steinberg, Li Chen, (unknown), Ann B. Moser, Hugo W. Moser, Garry R. Cutting, Nancy Braverman	91
20	From Expressed Sequence Tags to Peroxisome Biogenesis Disorder Genes 1996 ·Annals of the New York Academy of Sciences ·Gabriele Dodt, Nancy Braverman, David Valle, Stephen J. Gould	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact